{
    "paper_id": "PMC7166505",
    "metadata": {
        "title": "Immunoinformatics\u2010aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019\u2010nCoV",
        "authors": [
            {
                "first": "Vargab",
                "middle": [],
                "last": "Baruah",
                "suffix": "",
                "email": "vargabbarua@gauhati.ac.in",
                "affiliation": {}
            },
            {
                "first": "Sujoy",
                "middle": [],
                "last": "Bose",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The 2019 novel coronavirus (2019\u2010nCoV; Family Coronaviridae), also known as the Wuhan coronavirus, has created a global emergency the likes of which had not been seen since the 2003 severe acute respiratory syndrome (SARS) outbreak. As of 27th January 2020, the death toll from the coronavirus stood at 80, with more than 2500 confirmed cases in China, as well as in 11 other countries.\n1\n\n",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "The virus, first identified in Wuhan, Hubei, China, causes a contagious, respiratory infection. The incubation period is reportedly 2 to 10 days, and studies are underway to determine whether the transmission is possible from asymptomatic individuals.\n1\n Similar to other coronaviruses, 2019\u2010nCoV reportedly possesses a surface glycoprotein. In more established coronavirus pathogenesis, this protein has been shown to bind host cellular receptors and to mediate membrane fusion.\n2\n More importantly, it has been described as a potential vaccine target in both SARS\u2010coronavirus (SARS\u2010CoV) and Middle East respiratory syndrome coronavirus (MERS\u2010CoV).\n3\n, \n4\n\n",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "This study aimed to identify significant cytotoxic T cell (CTL) and B cell epitopes within the 2019\u2010nCoV surface glycoprotein using bioinformatic analysis. We also studied the potential interaction of the putative CTL epitopes with their corresponding representative major histocompatibility complex (MCH) class I supertypes most frequently observed in the Chinese population. We investigated hydrogen bonding, salt\u2010bridges, and residue\u2010residue contacts between CTL binding epitopes and the MHC class I molecules by molecular dynamics (MD) simulations.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Amino acid sequence of the 1273 AA, viral surface glycoprotein was retrieved in FASTA format from NCBI Protein Database (YP_009724390.1). Because of the novel nature of 2019\u2010nCoV, we compared the glycoprotein's alignment with the spike glycoprotein of SARS\u2010Cov (UniProt: P59594) to ensure sequence similarity in EMBOSS Water pairwise sequence aligner.\n5\n\n",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "NetCTL 1.2 server (http://www.cbs.dtu.dk/services/NetCTL) was used to identify CTL epitopes within the glycoprotein sequence.\n6\n NetCTL uses NetMHC server's artificial neural networks (ANNs) to predict MHC binding, NetChop\u20103.0 to predict C\u2010terminal cleavages and a weight matrix to calculate TAP transport efficiency to generate predictions. The scores of the three prediction methods are merged into a single score, which can be translated as sensitivity and specificity for the epitope\u2010MHC\u2010I binding event. We predicted MHC\u2010peptide\u2010binding for the following MHC class I supertypes\u2014A2, A3, B7, B44, and B62. Together, these supertypes account for the majority of human leukocyte antigen A (HLA\u2010A) (76.5%) and HLA\u2010B (67.1%) distribution in the Chinese population.\n7\n Epitopes with a combined score of >0.75 (sensitivity = 0.80, specificity = 0.97) were further confirmed in CTLPred (http://crdd.osdd.net/raghava/ctlpred),\n8\n where a consensus scoring approach was taken with thresholds of 0.51 (ANN) and 0.36 (support vector machines).",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "The three highest\u2010scoring epitopes for each supertype were selected for analyses of binding affinity to their corresponding representative supertypes in NetMHCpan 4.0 server which predicted epitope\u2010MHC\u2010I binding using ANN trained on quantitative binding data and mass spectroscopy\u2010derived MHC eluted ligands (http://www.cbs.dtu.dk/services/NetMHCpan).\n9\n Default threshold % ranks of 0.5 for strong binders, and 2 for weak binders were used.",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "Binding CTL epitopes were selected for homology modeling in PEP\u2010FOLD3, and structures with the lowest coarse\u2010grained energy were selected for protein\u2010protein docking with corresponding HLA chains using ZDOCK 3.0.2.\n10\n, \n11\n Complexes that scored the highest, based on interface atomic contact energy, shape complementarity, and electrostatics were selected for MD simulations in NAMD. Structures were solvated inside a TIP3P water box, and neutralized with Cl\u2212 and/or Na+, as required. Energy minimization was carried out in a series of conjugate gradients to ensure appropriate structure geometry. Equilibration with restrained solute atoms was performed in an NPT ensemble (310 K, 1 bar) with periodic boundary conditions, and constant temperature and pressure dynamics via Langevin dynamics and Nose\u2010Hoover Langevin piston respectively. Finally, free production runs, without positional restraints were carried out for 2 ns. Hydrogen bonds between epitopes and HLA chains were mapped in VMD with a two\u2010way donor\u2010acceptor distance of 3 \u00c5 and an angle of 20\u00b0 as thresholds. Residue\u2010residue contacts between epitopes and HLA chains were visualized in a contact map matrix, and salt bridge\u2010forming residues were identified using the oxygen\u2010nitrogen cut\u2010off distance of 3.2 \u00c5.",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "Sequential B cell epitopes within the surface glycoprotein were identified in BepiPred 2.0 (http://www.cbs.dtu.dk/services/BepiPred), and residues scoring above the default threshold of 0.5 were further confirmed in ABCPred, with default threshold of 0.51 and an overlapping filter (http://crdd.osdd.net/raghava/abcpred).\n12\n, \n13\n BepiPred 2.0 uses a random forest algorithm trained on epitope and non\u2010epitope amino acids validated from crystal structures, whereas ABCPred employs ANN using fixed\u2010length patterns trained on 700 B cell epitopes and 700 random non\u2010epitopes. To identify discontinuous B cell epitopes, we used Ellipro using the surface glycoprotein structure modeled in RaptorX, and the top five scoring epitopes were selected as significant.\n14\n, \n15\n The modeled structure was validated by the Ramachandran plot generated in RAMPAGE.\n16\n Antigenicity of all identified epitopes was predicted using VaxiJen 2.0.\n17\n Conservation of the sequential epitopes within spike proteins across bat coronavirus (Bt\u2010CoV, UniProt: A3EX94), SARS\u2010CoV, and MERS\u2010CoV (UniProt: K9N5Q8) were studied by multiple sequence alignment in Clustal Omega and visualized in NCBI Multiple Sequence Alignment Viewer.\n18\n\n",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "The surface glycoprotein of 2019\u2010nCoV was found to have 76.3% identity and 87.3% similarity with the spike glycoprotein of SARS\u2010CoV.",
            "cite_spans": [],
            "section": "RESULTS",
            "ref_spans": []
        },
        {
            "text": "We identified five CTL epitopes in the surface glycoprotein, with all five epitopes classified as strong binders to their corresponding MHC class I supertype representative (Table 1). During MDs simulations, we observed the CTL epitopes to bind with the peptide\u2010binding groove of MHC class I molecules, which is typically used for antigen presentation. The relevant residues of the epitopes and HLA chains in contact were mapped in a contact map matrix (Figure 1A). We observed salt bridge\u2010forming residues positioned over the viral epitopes in three of the five complexes, as well as continuous hydrogen bonding between epitopes and HLA chains maintained throughout the simulation in all complexes (Figure 1B,C). Mutations in salt bridge\u2010forming amino acids have been shown to weaken TCR recognition of MHC class I\u2010antigen complexes.\n19\n Also, the continuous formation of a set of hydrogen bonds between the MHC molecules and epitopes indicates an accommodating nature of the HLA chains to bind epitopes within the groove between the two helices.\n20\n Our results are therefore optimistic of ideal antigen presentation to CTLs.",
            "cite_spans": [],
            "section": "RESULTS",
            "ref_spans": [
                {
                    "start": 461,
                    "end": 463,
                    "mention": "1A",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 707,
                    "end": 711,
                    "mention": "1B,C",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 180,
                    "end": 181,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "We also identified three sequential B cell epitopes, and following modeling of 98% residues of the surface glycoprotein (P = 1.03e\u221215, uGDT = 946), we further identified five discontinuous B cell epitopes in the structure (Tables 2 and 3). Ramachandran plot indicated 94.2% (1194 AA) residues in the favored region, 5% (63 AA) residues in the allowed region, and 0.8% (10 AA) residues in the outlier region (Figure 2).",
            "cite_spans": [],
            "section": "RESULTS",
            "ref_spans": [
                {
                    "start": 415,
                    "end": 416,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 230,
                    "end": 231,
                    "mention": "2",
                    "ref_id": "TABREF1"
                },
                {
                    "start": 236,
                    "end": 237,
                    "mention": "3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "With the exception of CTL epitope\u2014VVNQNAQAL, which was found to have 100% identity with SARS\u2010CoV, all identified sequential CTL and B cell epitopes were at least partially unique to 2019\u2010nCoV, compared with Bt\u2010CoV, SARS\u2010CoV, and MERS\u2010CoV. CTL epitope\u2014EPVLKGVKL did not match any corresponding sequences of the other coronaviruses (Figure 3).",
            "cite_spans": [],
            "section": "RESULTS",
            "ref_spans": [
                {
                    "start": 338,
                    "end": 339,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "Rapid identification of immune epitopes is of crucial importance at the time of an impending pandemic. In this study, we attempted to identify significant CTL and B cell epitopes in the surface glycoprotein of 2019\u2010nCoV.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "CTLs can become activated after they detect infected cells presenting the offending viral antigens as part of surface antigen\u2010MHC\u2010I complexes. Successful presentation depends on the effective harboring of antigens by MHC\u2010I molecules via hydrogen bonds and salt bridge interactions that allow both high affinity with broader specificity.\n21\n After docking and structure refinement, we analyzed interactions between individual CTL epitopes and HLA chains of their corresponding MHC class I supertype representative by MDs simulations. We observed multiple, maintained hydrogen bond interactions, in addition to the presence of salt\u2010bridges in three complexes. Collectively, these interactions indicate a potentially successful presentation of the epitopes by MHC class I molecules, thereby activating CTLs and generating immune responses. We compared the epitopes obtained in our study with epitopes predicted in the spike protein of MERS\u2010CoV and SARS\u2010CoV.\n22\n, \n23\n We found one overlapping CTL epitope between MERS\u2010CoV and 2019\u2010nCoV with one gap and one mismatch (YLQPRTFLL/YKLQPLTFLL), and no comparable epitopes with SARS\u2010CoV. In addition to the activation of CTLs, successful immunogens need to generate a persistent humoral immunity and in our study, we identified three sequential and five discontinuous B cell epitopes in the surface glycoprotein.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "There are a few limitations of our study. Epitope detection in glycoproteins is often complicated by the presence of covalently attached glycans. Modeling viral glycoproteins with the associated glycans is especially challenging due to the lack of related structures, although attempts have been made in hepatitis C and rabies.\n24\n, \n25\n Second, similar to other RNA virus, coronavirus replication is error\u2010prone, with a reported mutation rate of 4 \u00d7 10\u22124 substitutions per site per year in SARS\u2010CoV.\n26\n This necessitates urgency in antiviral vaccine development before the identified epitopes are potentially rendered obsolete.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: CTL epitopes identified in 2019\u2010nCoV surface glycoprotein and their corresponding MHC class I supertype representative\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Sequential B cell epitopes identified in 2019\u2010nCoV surface glycoprotein\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 3: Discontinuous B cell epitopes identified in 2019\u2010nCoV surface glycoprotein\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: Interactions between cytotoxic T lymphocyte binding epitopes and human leukocyte antigen (HLA) chains of corresponding major histocompatibility complex class I supertype representative during molecular dynamics simulations. A, Residue\u2010residue contacts (X: epitope, Y: HLA) were mapped in contact map matrices. B, Salt bridge\u2010forming residues were detected in three complexes. C, Continuous hydrogen bonds were observed between all epitopes and corresponding HLA chains throughout the simulations",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: Discontinuous B cell epitopes in 2019\u2010nCoV surface glycoprotein and structure validation by Ramachandran plot. Left\u2014five discontinuous B cell epitopes identified in the modeled structure, detailed in Table 3. Right\u2014ramachandran plot indicated a high proportion of residues to be located within the favored and allowed regions. 2019\u2010nCoV, 2019 novel coronavirus",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: Visualization of frequency\u2010based differences in residues of sequential CTL and B cell epitopes across bat coronavirus, MERS\u2010coronavirus and SARS\u2010coronavirus. CTL, cytotoxic T lymphocyte; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Novel coronavirus (2019\u2010nCoV) situation report\u20107",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Structure, function, and evolution of coronavirus spike proteins",
            "authors": [],
            "year": 2016,
            "venue": "Annual Review of Virology",
            "volume": "3",
            "issn": "",
            "pages": "237-261",
            "other_ids": {
                "DOI": [
                    "10.1146/annurev-virology-110615-042301"
                ]
            }
        },
        "BIBREF2": {
            "title": "The spike protein of SARS\u2010CoV\u2014a target for vaccine and therapeutic development",
            "authors": [],
            "year": 2009,
            "venue": "Nat Rev Microbiol",
            "volume": "7",
            "issn": "",
            "pages": "226-236",
            "other_ids": {
                "DOI": [
                    "10.1038/nrmicro2090"
                ]
            }
        },
        "BIBREF3": {
            "title": "Prospects for a MERS\u2010CoV spike vaccine",
            "authors": [],
            "year": 2018,
            "venue": "Expert Rev Vaccines",
            "volume": "17",
            "issn": "",
            "pages": "677-686",
            "other_ids": {
                "DOI": [
                    "10.1080/14760584.2018.1506702"
                ]
            }
        },
        "BIBREF4": {
            "title": "Identification of common molecular subsequences",
            "authors": [],
            "year": 1981,
            "venue": "J Mol Biol",
            "volume": "147",
            "issn": "",
            "pages": "195-197",
            "other_ids": {
                "DOI": [
                    "10.1016/0022-2836(81)90087-5"
                ]
            }
        },
        "BIBREF5": {
            "title": "Large\u2010scale validation of methods for cytotoxic T\u2010lymphocyte epitope prediction",
            "authors": [],
            "year": 2007,
            "venue": "BMC Bioinformatics",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/1471-2105-8-424"
                ]
            }
        },
        "BIBREF6": {
            "title": "HLA supertype variation across populations: new insights into the role of natural selection in the evolution of HLA\u2010A and HLA\u2010B polymorphisms",
            "authors": [],
            "year": 2015,
            "venue": "Immunogenetics",
            "volume": "67",
            "issn": "",
            "pages": "651-663",
            "other_ids": {
                "DOI": [
                    "10.1007/s00251-015-0875-9"
                ]
            }
        },
        "BIBREF7": {
            "title": "Prediction of CTL epitopes using QM, SVM, and ANN techniques",
            "authors": [],
            "year": 2004,
            "venue": "Vaccine",
            "volume": "22",
            "issn": "",
            "pages": "3195-3204",
            "other_ids": {
                "DOI": [
                    "10.1016/j.vaccine.2004.02.005"
                ]
            }
        },
        "BIBREF8": {
            "title": "NetMHCpan\u20104.0: improved peptide\u2013MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data",
            "authors": [],
            "year": 2017,
            "venue": "The Journal of Immunology",
            "volume": "199",
            "issn": "",
            "pages": "3360-3368",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.1700893"
                ]
            }
        },
        "BIBREF9": {
            "title": "Improved PEP\u2010FOLD approach for peptide and miniprotein structure prediction",
            "authors": [],
            "year": 2014,
            "venue": "J Chem Theory Comput",
            "volume": "10",
            "issn": "",
            "pages": "4745-4758",
            "other_ids": {
                "DOI": [
                    "10.1021/ct500592m"
                ]
            }
        },
        "BIBREF10": {
            "title": "ZDOCK server: interactive docking prediction of protein\u2010protein complexes and symmetric multimers",
            "authors": [],
            "year": 2014,
            "venue": "Bioinformatics",
            "volume": "30",
            "issn": "",
            "pages": "1771-1773",
            "other_ids": {
                "DOI": [
                    "10.1093/bioinformatics/btu097"
                ]
            }
        },
        "BIBREF11": {
            "title": "BepiPred\u20102.0: improving sequence\u2010based B\u2010cell epitope prediction using conformational epitopes",
            "authors": [],
            "year": 2017,
            "venue": "Nucleic Acids Res",
            "volume": "45",
            "issn": "",
            "pages": "45-W29",
            "other_ids": {
                "DOI": [
                    "10.1093/nar/gkx346"
                ]
            }
        },
        "BIBREF12": {
            "title": "Prediction of continuous B\u2010cell epitopes in an antigen using recurrent neural network",
            "authors": [],
            "year": 2006,
            "venue": "Proteins: Struct, Funct, Bioinf",
            "volume": "65",
            "issn": "",
            "pages": "40-48",
            "other_ids": {
                "DOI": [
                    "10.1002/prot.21078"
                ]
            }
        },
        "BIBREF13": {
            "title": "ElliPro: a new structure\u2010based tool for the prediction of antibody epitopes",
            "authors": [],
            "year": 2008,
            "venue": "BMC Bioinformatics",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/1471-2105-9-514"
                ]
            }
        },
        "BIBREF14": {
            "title": "Template\u2010based protein structure modeling using the RaptorX web server",
            "authors": [],
            "year": 2012,
            "venue": "Nat Protoc",
            "volume": "7",
            "issn": "",
            "pages": "1511-1522",
            "other_ids": {
                "DOI": [
                    "10.1038/nprot.2012.085"
                ]
            }
        },
        "BIBREF15": {
            "title": "Structure validation by C\u03b1 geometry: \u03d5, \u03c8, and C\u03b2 deviation",
            "authors": [],
            "year": 2003,
            "venue": "Proteins: Struct, Funct, Bioinf",
            "volume": "50",
            "issn": "",
            "pages": "437-450",
            "other_ids": {
                "DOI": [
                    "10.1002/prot.10286"
                ]
            }
        },
        "BIBREF16": {
            "title": "VaxiJen: a server for prediction of protective antigens, tumour antigens, and subunit vaccines",
            "authors": [],
            "year": 2007,
            "venue": "BMC Bioinformatics",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/1471-2105-8-4"
                ]
            }
        },
        "BIBREF17": {
            "title": "Fast, scalable generation of high\u2010quality protein multiple sequence alignments using Clustal Omega",
            "authors": [],
            "year": 2011,
            "venue": "Mol Syst Biol",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/msb.2011.75"
                ]
            }
        },
        "BIBREF18": {
            "title": "Salt bridge\u2010forming residues positioned over viral peptides presented by MHC class I impacts T\u2010cell recognition in a binding\u2010dependent manner",
            "authors": [],
            "year": 2019,
            "venue": "Mol Immunol",
            "volume": "112",
            "issn": "",
            "pages": "274-282",
            "other_ids": {
                "DOI": [
                    "10.1016/j.molimm.2019.06.005"
                ]
            }
        },
        "BIBREF19": {
            "title": "Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation",
            "authors": [],
            "year": 2017,
            "venue": "Front Immunol",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3389/fimmu.2017.00292"
                ]
            }
        },
        "BIBREF20": {
            "title": "Molecular dynamics study of a complex between the human histocompatibility antigen HLA\u2010A2 and the IMP58\u201066 nonapeptide from influenza virus matrix protein",
            "authors": [],
            "year": 1992,
            "venue": "Eur J Biochem",
            "volume": "208",
            "issn": "",
            "pages": "101-113",
            "other_ids": {
                "DOI": [
                    "10.1111/j.1432-1033.1992.tb17163.x"
                ]
            }
        },
        "BIBREF21": {
            "title": "Epitope\u2010based peptide vaccine design and target site depiction against Middle East respiratory syndrome coronavirus: an immune\u2010informatics study",
            "authors": [],
            "year": 2019,
            "venue": "J Transl Med",
            "volume": "17",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/s12967-019-2116-8"
                ]
            }
        },
        "BIBREF22": {
            "title": "Residue analysis of a CTL epitope of SARS\u2010CoV spike protein by IFN\u2010gamma production and bioinformatics prediction",
            "authors": [],
            "year": 2012,
            "venue": "BMC Immunol",
            "volume": "13",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/1471-2172-13-50"
                ]
            }
        },
        "BIBREF23": {
            "title": "Computational modeling of hepatitis C virus envelope glycoprotein structure and recognition",
            "authors": [],
            "year": 2018,
            "venue": "Front Immunol",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3389/fimmu.2018.01117"
                ]
            }
        },
        "BIBREF24": {
            "title": "Predicted 3D model of the rabies virus glycoprotein trimer",
            "authors": [],
            "year": 2016,
            "venue": "BioMed Res Int",
            "volume": "2016",
            "issn": "",
            "pages": "1-11",
            "other_ids": {
                "DOI": [
                    "10.1155/2016/1674580"
                ]
            }
        },
        "BIBREF25": {
            "title": "Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis",
            "authors": [],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "",
            "pages": "1602-1603",
            "other_ids": {
                "DOI": [
                    "10.1128/jvi.78.3.1602-1603.2004"
                ]
            }
        }
    }
}